Pharma companies still fail to embrace social media

As the pharmaceutical industry awaits social media guidance from the FDA, drug makers have avoided involvement over regulatory fears.

Although social media use in healthcare continues to grow, a new study has found that about half of the top 50 pharmaceutical companies are not actively engaging with patients through social media and the same amount of companies are not using social media effectively. More specifically, as drug makers experiment with social media to engage consumers, they are reluctant to use these tools to bolster their efforts in designing and developing clinical trials.

Link to full article

Originally published on insidecounsel.com